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Abstract
In mammals, cyclic GMP and cGMP-dependent protein
kinases (cGKs) have been implicated in the regulation of
many neuronal functions including long-term potentiation and
long-term depression of synaptic ef®cacy. To develop
Caenorhabditis elegans as a model system for studying the
neuronal function of the cGKs, we cloned and characterized
the cgk-1 gene. A combination of approaches showed that
cgk-1 produces three transcripts, which differ in their ®rst exon
but are similar in length. Northern analysis of C. elegans RNA,
performed with a probe designed to hybridize to all three
transcripts, con®rmed that a major 3.0 kb cgk-1 transcript is
present at all stages of development. To determine if the
CGK-1C protein was a cGMP-dependent protein kinase,
CGK-1C was expressed in Sf9 cells and puri®ed. CGK-1C
shows a Ka of 190 ^ 14 nM for cGMP and 18.4 ^ 2 mM for
cAMP. Furthermore, CGK-1C undergoes autophosphorylation
in a cGMP-dependent manner and is inhibited by the
commonly used cGK inhibitor, KT5823. To determine which
cells expressed CGK-1C, a 2.4-kb DNA fragment from the
promoter of CGK-1C was used to drive GFP expression. The
CGK-1C reporter construct is strongly expressed in the ventral
nerve cord and in several other neurons as well as the
marginal cells of the pharynx and intestine. Finally, RNA-
mediated interference of CGK-1 resulted in movement defects
in nematode larvae. These results provide the ®rst demon-
stration that cGMP-dependent protein kinase is present in
neurons of C.elegans and show that this kinase is required for
normal motility.
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As intracellular second messengers, the cyclic nucleotides
alter cellular functions through a variety of mechanisms.
cGMP is an intracellular second messenger that mediates the
action of nitric oxide (NO) and natriuretic peptide hormones
in the nervous system (Butt et al. 1993). NO activates
soluble guanylyl cyclase (Arnold et al. 1977), while the
particulate guanylyl cyclases are controlled by natriuretic
peptides, guanylin and enterotoxins (Field et al. 1978).
Within cells cGMP has several direct targets: cGMP-
regulated phosphodiesterases (Francis et al. 1980),
cGMP-gated cation channels and cGMP-dependent protein
kinases (cGKs). However, the best characterized effectors of
cGMP are the cGKs.
Mammals contain two different cGKs, designated type I
(cGKI) and type II (cGKII). cGKIs are predominately
cytoplasmic and are highly expressed in Purkinje cells
(Lohmann et al. 1981) as well as other regions of the brain.
cGKII is also expressed in the brain (Uhler 1993) but its
distribution differs from that of cGKI (el-Husseini et al.
1995). The neuronal functions of the cGKS are not clearly
de®ned; however, cellular regulation by cGKs outside of the
nervous system is thought to be similar to that within the
neurons. cGKI regulates intracellular calcium levels,
particularly in smooth muscle, where cGKI mediates
muscle relaxation (Lincoln 1989). cGKI is also thought
to play a role in platelet aggregation (Horstrup et al. 1994),
olfaction (Nakamura and Gold 1987), and long-term
depression of neurons (Hartell 1996). cGKII has been
implicated in the regulation of ion transport in
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intestinal cells, where it phosphorylates the cystic ®brosis
transmembrane conductance regulator (CFTR) protein
(Forte et al. 1992).
The existence of multiple intracellular cGMP receptors
and the lack of well characterized physiological substrates
for the cGKs have complicated attempts to de®ne the
neuronal mechanisms of cGK action. The nematode
Caenorhabditis elegans represents a unique system in
which to study the neuronal function of cGKs. C. elegans
is a well-de®ned organism with 959 somatic cells, which are
organized into nervous, muscular, reproductive, hypo-
dermal, excretory and digestive systems (Hodgkin et al.
1998). The development of C. elegans has been studied in
great detail and the lineage of each neuron in the worm is
known (Sulston and Horvitz 1977). Furthermore, many
aspects of C. elegans development are controlled by
signalling cascades that are functionally similar to the
signalling cascades present in mammals (Patterson and
Padgett 2000). In addition, powerful genetic techniques
simplify identi®cation of novel genes and allow rapid
characterization of a gene's function. Finally, the
completion of the C. elegans genome sequencing
project permits rapid cloning of genes of interest
(Hodgkin et al. 1998) including potential neuronal cGK
substrates.
We report here the genetic and biochemical characteriza-
tion of a cGMP-dependent protein kinase from C. elegans
which is expressed in several types of neurons. In addition,
we show that RNA-mediated interference of this cGK
causes a defect in motility.
Material and methods
Strains and nomenclature
The genetic nomenclature for C. elegans was described previously
(Horvitz et al. 1979). We use capital letters and plain font to
indicate the protein encoded by a gene. Thus, the protein produced
by the cgk-1 gene is CGK-1. All experiments were done using the
Bristol strain N2 (Brenner 1974).
Isolation of cgk-1 cDNA
Degenerate primers cGK5.1 (GGG AGA TCT GAG CTG GCT
AT (C/T) CT (A/C/G/T) TA (C/T) AA (C/T) TG) and cGK3.1
(GGG GAA TAC CCG CA(A/G) AA(A/C) GTC CA(A/C/G/T)
GT(C/T) (TT) were used in PCR reactions with pooled phage
DNA from a C. elegans cDNA library (Stratagene, La Jolla, CA,
USA) as template. The ampli®cation resulted in a ,1.0 kb band,
which was digested with BglII and EcoRI. The digestion products
(,530 bp and ,490 bp) were cloned into pBluescript(SK)
(Stratagene) and pGem3Z(1) (Promega, Madison, WI, USA),
respectively. The inserts were sequenced and found to encode a
protein showing homology with bovine cGK1a.
Random primer extension was used to generate radiolabeled
probes for screening ,1.2  106 recombinant lZap II phage from
a C. elegans mixed staged cDNA library (Stratagene). Inserts from
three hybridizing clones were sequenced on both strands, using
speci®c oligonucleotide primers and Sequenase DNA polymerase
(Amersham, Piscataway, NJ, USA).
RT-PCR and 5 0 RACE analysis
A Superscript kit (Life Technologies, Rockville, MD, USA) was
used to reverse transcribe 500 nanograms of polyA 1 RNA with a
SL1 sense primer (GGG TCT AGA TTA ATT ACC CAA GTT
TGA) and a 3 0 antisense primer directed against the CGK-1C
cDNA sequence (CCC GTC GAC AGA GCT CCC TCA CGT
GAA ACT TGC). The resulting 0.7 kb product was digested with
SalI and XbaI and ligated into pBluescript(KS) (Stratagene).
Multiple independent subclones were sequenced with the Prism
kit (Applied Biosystems, Foster City, CA, USA).
Brie¯y, 5 0 RACE was performed as described (Frohman et al.
1988). The ®rst PCR reaction was performed using tailed ®rst-
strand cDNA and primers QT (CCA GTG AGC AGA GTG ACG
AGG ACT CGA GCT CAA GCT TTT TTT TTT TTT TT), QON
(CCA GTG AGC AGA GTG ACG AGG A), and a speci®c cgk-1
internal primer (TTC TCA AAA TTC GTC GGC TCT GCT). The
second PCR reaction used the product of the ®rst reaction as
template and primer Q1N (CCA GTG AGC AGA GTG ACG AGG
A) and a second cgk-1 primer (GTG GAG ATG GTG ATG GTG
GTT GTC). The resulting 650 bp product was cloned and
sequenced.
RNA isolation for northern blot
Acid guanidinium thiocyanate±phenol±chloroform extraction
(Chomczynski and Sacchi 1987) was used to isolate total RNA
from staged nematodes grown in liquid culture (Sulston and
Brenner 1974). Total RNA was separated on a formaldehyde gel,
transferred to a positively charged nylon membrane (MSI) and
hybridized with an antisense RNA probe. Plasmid pGEMT-
H6CGK-1C (see below) was used as template in a PCR reaction
with primers cgk-1for (TGA TAC GTG ACG CCG TGC) and
T7cgk-1rev (GGA TCC TAA TAC GAC TCA CTA TAG GGA
GAA CGA AGA ATG CGT CAC CC) to amplify an ,570 bp
fragment covering exon 3 to exon 7. This PCR product was used to
generate a radiolabeled RNA probe for northern blotting, which
should detect all three cgk-1 isoforms. As a control for RNA
loading, the same blots were hybridized with an RNA probe to the
26S RNA.
Expression and puri®cation of CGK-1C
To aid in puri®cation, codons for six histidine residues were
appended to the amino terminal coding region of CGK-1C. pCGK-
1C plasmid DNA was used as a template, and primers (GGG ATC
CCA CCA TGC ACC ATC ACC ATC ATC ACC ACT ATG GGT
CCA GT) and (TGG CTG GCT TAT TCT CA) were used to
amplify the coding region of the cDNA. The resulting PCR
fragment was subcloned into pGEMT (Promega) and designated
pGEMT-H6CGK-1C. The insert containing the histidine-tagged
amino terminal CGK-1C cDNA was excised from pGEMT-
H6CGK-1C with enzymes EcoRI and XhoI and subcloned into
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plasmid PZ8-CGK-1C, which contained the full length CGK-1C
coding region minus the amino terminal region. The resulting
plasmid was designated H6PZ8-CGK-1C. The histidine tagged full
length CGK-1C cDNA insert was excised from H6PZ8-CGK-1C
with enzymes SpeI and NotI and subcloned into the bacmid vector
pFastBac (BRL) creating pFastBac-H6CGK-1C. This plasmid was
puri®ed and used to transfect a culture of Sf9 cells. Supernatant
from the primary infection was used in subsequent infections to
increase the viral titer.
For protein expression, 500 mL of Sf9 culture was infected at a
density of 6  106 cells/mL. After 72 h, cells were collected by
centrifugation and stored at 2 708C. CGK-1C protein was puri®ed
over a Ni-NTA-agarose af®nity resin column (Qiagen, Valencia,
CA, USA) to apparent homogeneity as determined by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and Commassie blue staining.
Kinase, autophosphorylation and dissociation assays
Kinase assays (Gamm et al. 1995) were performed at 308C using
the synthetic heptapeptide Arg-Lys-Arg-Ser-Arg-Ala-Glu
(H2Btide) (Glass and Krebs 1982) as phosphate acceptor and
puri®ed CGK-1C protein (1.5 nm ®nal concentration) from Sf9
cells. KT5823 inhibitor assays were similar to the kinase assay
described above, except that the cyclic nucleotide concentration
was held constant at 2 mm and increasing concentrations of
inhibitor were used.
Autophosphorylation assays (de Jonge and Rosen 1977) also at
308C were also similar to the kinase assay, except that bovine
serum albumin (BSA) and substrate peptides were omitted from the
reaction mix. The reaction mixture consisted of the kinase buffer
described above and a ®xed concentration (0.2 mm) of CGK-1C
protein with or without 10 mm cGMP. [32P] incorporation was
determined by excising the CGK-1C band from the blot and
scintillation counting.
[3H]-cGMP dissociation assays were performed at 308C as
described (Taylor and Uhler 2000) except that puri®ed CGK-1C
was added to the reaction mixture.
Construction and analysis of cgk-1C promoter::GFP
transgene
Two primers (AGC TTG CAT GCC TGC AGG TAT GCA AGG
AGT ACT TCG ACT) and (CTG GCC AAT CCC GGG GGA
TCC ATA CAT TTG GTG AGA) were used in a PCR reaction
where C. elegans genomic DNA was the template. A 2.4-kb DNA
fragment that included the start codon and upstream sequence of
CGK-1C was subcloned into the TA-cloning vector (Invitrogen).
The 2.4 kb fragment was released with BamHI and PstI and
subcloned into pPD95.69 (provided by Andrew Fire, Carnegie
Institution, Washington, DC, USA). The resulting plasmid, pCGK-
1C::GFP was transformed into Escherichia coli, puri®ed by
miniprep (Qiagen), ethanol precipitated and resuspended in 1X
injection buffer (Fire 1986). Finally, pcgk-1C::GFP (at 5, 15 or
25 ng/mL) and pRF4 [rol-6(su1006dm)] (at 100 ng/mL) were
injected into young adult nematodes using the method outlined
by Mello et al. (1991). The Rol-6 phenotype was used to select
animals that carried the pcgk-1C::GFP construct.
The phasmids of worms expressing the pcgk-1C::GFP construct
were stained with DiIC18 (St John 1991) for 30 min, washed,
treated with 10 mm NaN3, placed on a slide containing an agar pad
and then photographed using confocal microscopy.
RNA-mediated interference
To prepare double-stranded RNA (dsRNA), we used PCR to
generate a template containing nucleotides 4±455 of the fog-3
cDNA and separately used PCR to generate a template
containing nucleotides 119±463 (exon 2 to exon 4) of the cgk-1C
cDNA. Both DNA fragments had inward directed T7 promoters at
each end. We prepared dsRNAs by in vitro (Megascript; Ambion,
Austin, TX, USA) transcription, precipitation and resuspension in
1X injection buffer (Fire 1986), and allowed the two strands to
anneal at 378C for 1 h. The ®nal concentration was estimated to be
1±2 mg/mL by ethidium bromide staining. Injections were carried
out as described by Guo and Kemphues (1995) and Fire et al.
(1998).
Fig. 1 The structure and organization of
the C. elegans cgk-1 gene. (a) cgk-1 is
alternatively spliced at exon 1. Exons are
represented by black rectangles. Exon 1A
is 257 nucleotides in length not including
the SL1 spliced leader sequence. Exon 1B
is at least 33 nucleotides in length (see
text). Exon 1C is 102 nucleotides in length.
Exons 2±10 appear common to all the cgk-
1 isoforms. (b) The predicted amino acid
sequences of exons 1A, 1B and 1C. Exon
1A encodes 52 amino acids and has a
potential autophosphorylation site denoted
by the asterick. Exon 1B encodes nine
amino acids. Exon 1C encodes 21 amino
acids.
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Results
Isolation and characterization of cgk-1 cDNAs
One pair of primers based on regions of homology shared by
bovine, human and Drosophila cGK sequences successfully
ampli®ed a 1-kb fragment with high homology to other
cGKs from a mixed stage C. elegans cDNA library
(Stratagene). We used hybridization screening to isolate
the full-length coding region corresponding to this fragment.
Comparison of the cgk-1 sequence with genomic DNA
(1998) showed that cgk-1 contains 10 exons and is located
on chromosome IV. However, a BLAST search against
expressed sequence tags (ESTs) from C. elegans revealed
the presence of additional cgk-1 transcripts (Fig. 1a). Each
of the three transcripts is predicted to be ,3000 nt long, and
shares exons 2 through 10, but the translation start sites for
each transcript is distinct. We independently isolated two
cDNA sequences corresponding to exon 1A by 5 0RACE;
these transcripts were both trans-spliced with the SL1 leader
sequence. Exon 1A also encodes a potential autophos-
phorylation site (Fig. 1b) that is not present in amino acids
encoded by exons 1B and 1C. In addition, we isolated three
cDNA fragments corresponding to exon 1C from a cDNA
library, following ampli®cation with SL1 and internal
primers. Finally, we have detected rare exon 1B transcripts
in RT-PCR experiments (data not shown).
Cgk-1 is expressed throughout development
To determine cgk-1 mRNA levels during development,
northern blots of staged total RNA were probed using an
antisense RNA probe speci®c for exons 3±7 of cgk-1. The
probe detected a 3.0-kb transcript expressed at all stages of
development (Fig. 2). Fig. 2(c) shows normalized mRNA
levels following phosphoimager analysis. A small increase
in the expression of total cgk-1 transcripts is seen in adult
stage nematodes.
The sequence of CGK-1C predicts a protein with high
similarity to known cGMP-dependent protein kinases
Because the ®rst exon of each transcript is short, the three
predicted CGK-1 proteins are extremely similar (Fig. 1b).
Overall CGK-1C shows 48% amino acid identity with
human cGKIa (Sandberg et al. 1989), 43% amino acid
identity with human cGKII (Orstavik et al. 1996), 44%
amino acid identity with Drosophila cGKI and 43% amino
acid identity with Drosophila cGKII (Kalderon and Rubin
1989). Homology is highest in the catalytic domain (62%
identity with human cGKI, 57% identity with human cGKII,
58% identity with the Drosophila cGKI and 61% identity
with Drosophila cGKII). CGK-1C has a predicted ATP
binding site corresponding to residues 442±455 as well as a
conserved lysine residue (K468) that is found in serine/
threonine protein kinases (Fig. 3).
CGK-1C has the biochemical properties of a
cGMP-dependent protein kinase
To determine if CGK-1C is preferentially activated by
cGMP over cAMP, we performed radiometric kinase assays
with increasing concentrations of cGMP or cAMP. The
synthetic peptide RKRSRAE was used as substrate in these
assays because it has been shown to be a good substrate for
mammalian cGKs (Glass and Krebs 1982). Activation
constants for both cGMP and cAMP were determined by
Eadie/Hofstee plots (Eadie 1942; Hofstee 1942). CGK-1C
has a Ka of 190 ^ 14 nm for cGMP and 18.4 ^ 2 mm for
cAMP (Fig. 4a). CGK-1C activation constants for cGMP
and cAMP are very similar to activation constants
determined for other members of the cGMP-dependent
protein kinase family. For example, the mammalian
cGKIa has a Ka of 190 ^ 14 nm for cGMP and
18.4 ^ 2 mm for cAMP (Gamm et al. 1995). Furthermore,
CGK-1C has a Vmax of 1.47 mmole/min/mg of protein
for cAMP and 2.1 mmole/min/mg of protein for cGMP
which is comparable with the Vmax values obtained for
bovine cGK Ia (4.4 mmole/min/mg with cGMP) and mouse
cGK II (1.2 mmole/min/mg with cGMP) (Gamm et al.
1995).
Fig. 2 Developmental northern analysis. Staged speci®c total RNA
was hybridized to antisense C. elegans cgk-1 probe. (a) A single
3.0 kb transcript was detected at all stages of development. The
probe was generated from exons 3 to 7 and should recognize all
three cgk-1 mRNAs. (b) A 26S ribosomal RNA probe was used to
test for loading errors. (c) Graph representing normalized mRNA
levels following phosphoimager analysis.
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KT5823 is a ATP analog inhibitor of mammalian cGKs
(Kase et al. 1987) and is used widely for in vivo applications
in mammalian systems (Grider 1993; Fujii et al. 1995). If
CGK-1C is functionally similar to other cGMP-dependent
protein kinases, it should be inhibited by KT5823. To
assess CGK-1C sensitivity to KT5823 in vitro, kinase assays
were performed in the presence of varying KT5823
concentrations (see Materials and methods). KT5823
inhibited CGK-1C with an IC50 of 3.8 mm (Fig. 4b).
To determine if puri®ed CGK-1C undergoes autophos-
phorylation after activation by cGMP, recombinant CGK-1C
was incubated with [g-32P]-ATP in the presence or absence
of 10 mm cGMP. The reactions were terminated by addition
of SDS loading buffer, and the samples analyzed by
Fig. 3 Homology of C. elegans CGK-1C
amino acid sequence to known cGMP-
dependent protein kinase amino acid
sequences. The predicted amino acid
sequence of the C. elegans CGK-1C (top)
is shown compared with human cGK I (Hs
cGKI)and II (Hs cGKII) and the Drosophila
cGK I (Dm cGKI) and II (Dm cGKII). Posi-
tions where two or more sequences show
identity are indicated by black shading. The
amino acid numbers of the various
sequences are indicated at the right of the
diagram.
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SDS-PAGE. These experiments suggest that CGK-1C is
autophosphorylated rapidly with maximal autophos-
phorylation occurring within 5 min (data not shown).
Quantitation of phosphate incorporation demonstrated that
only 0.02 mol of phosphate were incorporated per mol
of enzyme in 5 min assays in the absence of cGMP;
however, 1.75 mol of phosphate were incorporated in
the presence of cGMP. This value is similar to that
of cGKIû which incorporates ,2 mol of phosphate per
mol of enzyme in autophosphorylation assays (Chu et al.
1998).
Mammalian cGKs have a characteristic biphasic
dissociation curve for cGMP. The biphasic curve is the
result of two distinguishable cyclic nucleotide binding
sites: one high af®nity and one low af®nity site per cGK
monomer (Corbin and Doskeland 1983; Wolfe et al. 1989a).
To assess CGK-1C binding properties, we measured t1/2-
values for its cyclic nucleotide binding sites by study-
ing the time course of [3H]-cGMP dissociation. Our
results demonstrate that C. elegans CGK-1C exhibits a
biphasic pattern (Fig. 5). The t1/2 for dissociation from the
rapidly dissociating site in CGK-1C was ,0.15 min and
t1/2 from the slowly dissociating site was ,8 min. These
dissociation values are similar to dissociation values
described for mammalian cGKs. For example, cGKIa
has a t1/2 for the fast and slow sites of 0.5 min and
25 min, respectively (Gamm et al. 1995). The stoichio-
metry of cGMP binding (0.7±0.8 mol of cGMP per mole
of enzyme) was signi®cantly lower than the expected
value of 2 mol of cGMP per mole of enzyme. We believe
this is due in part to occupancy of the cGMP-binding sites
by cyclic nucleotides derived for the Sf9 cells during
protein production.
The cgk-1C promoter drives GFP expression in neurons
as well as other cell types
To elucidate where CGK-1C is expressed in C. elegans we
used its promoter to drive expression of a GFP transgene
which served as a reporter (see Materials and methods). The
2.4 kb region immediately upstream of cgk-1C was cloned
into a promoterless GFP expression vector and injected
with rol-6(su1006dm) into young adult nematodes. The
rol-6(su1006dm) gene produces a rolling phenotype when
expressed (Mello et al. 1991) and allowed rapid selection of
animals that had formed extrachromosomal arrays that
might express the pcgk-1C::GFP construct. Six transgenic
lines were isolated and examined for GFP expression. All
lines had similar expression patterns. We observed ¯uores-
cence in a subset of neurons in the head, nerve ring, and
ventral nerve cord including some motor neurons (Figs 6a
and b). Furthermore, pcgk-1C::GFP expression was found in
several neurons in the tail. One of these neurons was PQR,
which was identi®ed by its axon morphology and its position
relative to the phasmid neurons (Fig. 6c); PQR has been
Fig. 4 Kinase activities of CGK-1C. (a) The kinase activity of
CGK-1C protein (1.5 nM) was measured in the presence of
increasing cyclic nucleotide concentrations. Filled circles indicate
activation by cGMP and open circles indicate activation by cAMP.
Activity was determined and expressed as the percentage of the
highest CGK-1C activity obtained for cGMP and cAMP, respectively.
These experiments were performed six times for each cyclic nucleo-
tide concentration. (b) Increasing concentrations of cGMP-dependent
protein kinase inhibitor KT5823 inhibits CGK-1C activity with an IC50
of 3.8 mM. Activity in these experiments was expressed as a
percentage of CGK-1 activity in the absence of inhibitor. These
experiments were performed three times with similar results.
Fig. 5 CGK-1C has a biphasic dissociation for [3H]-cGMP. Brie¯y,
450 nM of CGK-1C was incubated in KPEH buffer, with 1 mM cGMP
and 3.2 mM [3H]-cGMP, for 30 min. To measure [3H]-cGMP dissocia-
tion kinetics from the two cGMP binding sites, 100X cold cGMP was
added to the reaction mix and vortexed, following which samples
were collected and analyzed (see Materials and methods). The t1/2
for dissociation from the fast dissociating site in CGK-1C was
,0.15 min and the t1/2 from the slow dissociating site was ,8 min.
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shown to express a guanylyl cyclase (Yu et al. 1997). GFP
was also expressed in the pharyngeal marginal cells, body
muscle, intestine, vulval muscles, and spermatheca (data not
shown).
RNA-mediated interference against cgk-1 causes
impaired movement
To examine potential physiological roles of CGK-1 in
C. elegans, RNA-mediated interference experiments were
performed (Fire et al. 1998). Double-stranded RNA was
generated from nucleotides 119±463 of the coding region of
cgk-1C and injected into the germline of young adult
animals at ,1 mg/mL. We observed the XX self-progeny of
these animals and all of the F1 animals developed with
normal size and morphology. However, many of these
animals moved slowly and irregularly.
To study this phenotype further, blind tests were
conducted using wild type (N2) animals, F1 animals from
hermaphrodites injected with fog-3 dsRNA (Chen et al.
2000) as a control and F1 animals from hermaphrodites
injected with cgk-1 dsRNA. The animals were placed on
foodless plates to encourage foraging and the number of
complete body ¯exes per minute was counted. We observed
serious defects in movement among most of the cgk-1
animals, but not among the controls (Fig. 6d). The small
variation in phenotype of the cgk-1(RNAi) worms might
results from varying concentrations of dsRNA found in the
young animals.
Discussion
CGK-1C is a cGMP-dependent protein kinase
The cgk-1 gene of C. elegans produces three transcripts,
which encode proteins that differ at their amino termini but
are otherwise identical. In order to eludicate the function of
these proteins, we selected one, CGK-1C for biochemical
characterization. Two biochemical tests indicate that this
protein is indeed a cGMP-dependent protein kinase. First,
we measured the ability of CGK-1C to phosphorylate a
synthetic peptide, and found that CGK-1C was preferen-
tially activated by cGMP over cAMP. In fact, we observed
that the Ka for cGMP was 97-fold lower than for cAMP.
Second, we showed that the ability of CGK-1C to
phosphorylate the peptide substrate was inhibited by
KT5823, a compound shown previously to inhibit cGMP-
dependent protein kinases in mammals. CGK1-C undergoes
autophosphorylation in the presence of cGMP, like other
cGMP-dependent protein kinases. Additionally, CGK-1C
showed a biphasic dissociation curve for cGMP that
resembles those of other cGMP-dependent protein kinases.
Taken together, these results suggest that the sequence
similarity between CGK-1C and other cGMP-dependent
protein kinases re¯ects common mechanisms of activation
and regulation.
What about the two other products of the cgk-1 gene? We
have not tested their functions biochemically, but their
considerable sequence identities suggest that their activities
are similar to those of CGK-1C. The mammalian cGKIa
Fig. 6 Promoter cgk-1C::GFP is expressed in some neurons in
C. elegans. Transgenic animals with a GFP construct under the con-
trol of the 2.4 kb promoter of cgk-1C were imaged using confocal
microscopy. (a) L2 animal expressing GFP in the pharyngeal
marginal cells, neurons in the head, and ventral nerve cord (arrow).
(b) Enlargement of a segment of the ventral nerve cord. Arrow indi-
cates a motor neuron, which was identi®ed by location and axonal
morphology. (c) Image of the tail region in an adult animal. Arrow
indicates GFP expression in neuron PQR, which was identi®ed by
location and axonal morphology. DiIC18-®lled phasmids were
detected by the red ¯uorescence. (d) dsRNA was generated from
the cDNA of cgk-1C, injected into young adult animals and XX-self-
progeny were observed. To quantitate the motility defect, blind tests
were performed on F1 progeny from animals injected with cgk-1
dsRNA, fog-3 dsRNA or N2 animals (see text) and the number of
complete body ¯exes (bends) per minute was determined. Eighteen
of 25 cgk-1(RNAi) animals made fewer than 10 bends/min and had
median movement value of 2 bends/min. Progeny for N2 animals
and fog-3 had a median value of 25 and 24 bends/min, respectively.
Similar experiments were performed two additional times, but with
additional controls.
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and b also only differ in their amino terminal sequences
(Lincoln et al. 1988; Wernet et al. 1989; Wolfe et al. 1989b)
and these differences are thought to regulate protein±protein
interactions. For example, the amino terminal sequences of
cGKIa are required for binding to the myosin-binding
subunit (MBS) of myosin phosphatase (Surks et al. 1999).
By contrast, cGKIû and cGKII do not bind MBS. Similarly,
cGKIû has been show to speci®cally associate with the
IP3R-associated cGMP kinase substrate (IRAG) (Schloss-
mann et al. 2000) whereas cGKIa and cGKII have not been
shown to associate with IRAG. We speculate that the
different amino terminal sequences present in the CGK-1
isoforms might regulate protein±protein interactions or
localization.
Why does cgk-1 produce three similar transcripts?
cgk-1 is by no means unique. The C. elegans kin-1 gene,
which encodes a cAMP-dependent protein kinase catalytic
subunit, has ®ve alternative ®rst exons (Tabish et al. 1999).
One possibility is that the crucial factor is not the difference
between the alternative ®rst exons, but instead between the
promoter regions attached to these exons. Since these
promoter regions are large for C. elegans, it is not
unreasonable to suspect that each drives the expression of
cgk-1 in a complex and distinct set of cells. Alternatively,
the different ®rst exons might themselves play an important
role in the regulation of each protein's activity, as we
speculated above. In this regard, some versions of KIN-1
can be myristoylated, but others cannot (Tabish et al. 1999).
Nematodes have two cGKs
Humans, mice and fruit ¯ies each have two distinct cGK
genes, which encode a type-I and a type-II cGMP-dependent
protein kinase. In mammals, evidence suggests that the two
types of cGKs serve different physiological functions
(Lohmann et al. 1997). We used blast searches to screen
the completed C. elegans genome (1998) and identi®ed a
second potential cGK gene, which we are currently
characterizing. Thus, nematodes, like other animals, are
likely to contain two types of cGMP-dependent protein
kinases. These two forms of the protein may have arisen
early in evolution from a common ancestor and have been
preserved since that time, or might instead have arisen
independently in each lineage. Our sequence analysis of
CGK-1 suggests that it is most likely to have arisen from the
same ancestral gene that gave rise to mammalian cGKII and
Drosophila cGKI (Jarchau et al. 1994) (unpublished results).
What functions does CGK-1 regulate in C. elegans?
We observed movement defects following RNA-mediated
interference of cgk-1, which suggest that cgk-1 functions in
the neuro-musculature system; however, we do not rule the
possibility that movement defects could be due to inhibition
of cgk-1 in non-neuronal cells. CGK-1 might also control
behaviors that were not affected by RNAi, because RNAi is
not equally effective in all tissues, or because a second
cGMP-dependent protein kinase might be functionally
redundant to CGK-1 in some cells. The isolation of cgk-1
de®cient mutants should help complete our analysis of the
role of CGK-1 in C. elegans.
In Drosophila, higher activity of the foraging gene (for)
(also known as dg2) which encodes a neuronal cGMP-
dependent protein kinase causes a more active foraging
behavior than sitter strains which have lower for activity
(Osborne et al. 1997). Similar roles for cGKs in mouse
behavior have not been reported; however, mice lacking
cGKI show erectile dysfunction and impaired smooth
muscle relaxation (Pfeifer et al. 1998; Hedlund et al.
2000) while cGKII de®cient mice exhibit dwar®sm and
intestinal secretory defects (Pfeifer et al. 1996).
Mammalian cGKs are known to regulate intracellular
Ca21 levels in smooth muscle cells (Lincoln 1989). High
calcium/calmodulin levels in muscle activate the myosin
light chain kinase which phosphorylates myosin light chain,
the ®rst step in muscle contraction (Somlyo and Somlyo
1994). By lowering Ca21 levels, cGKs indirectly inactivate
myosin kinase, causing muscle relaxation. cGKI can
regulate intracellular Ca21 levels by inhibiting phospholi-
pase C activation (Barnett et al. 1995) and the generation of
inositol 1,4,5-trisphosphate (IP3). cGK also phosphorylates
the IP3 receptor (Komalavilas and Lincoln 1994) directly,
which attenuates Ca21 release. Additionally, cGK activates
Ca21-ATPases in the plasma membrane of the sarcoplasmic
reticulum (Cornwell et al. 1991), which lower intracellular
cytosolic Ca21 levels (Gonzalez et al. 1996).
Within Purkinje cell neurons, the phosphatase inhibitor
G-substrate in a well characterized substrate for cGKI and
G-substrate phosphorylation can cause activation of genes
containing cAMP-responsive elements (Hall et al. 1999).
Finally, voltage-operated Ca21 channels and l-type calcium
channels (Chik et al. 1995) can be directly phosphorylated
and inhibited by cGK and may be important neuronal
substrates for mammalian cGKs. By analogy, the inter-
ference of cgk-1 in C. elegans might affect the regulation of
calcium channels or phosphatase regulation in neurons,
thereby impairing neurosecretion and movement.
Future studies
C. elegans is an excellent system for identifying genes that
are important to function of the nervous system. UNC-4 is a
neuronally expressed homeodomain transcription factor
which speci®es presynaptic input in the ventral nerve cord
in C. elegans. unc-4 mutants have impaired backward
motility which is caused by miswiring of VA motor neurons
(Miller and Niemeyer 1995). Like unc-4, cgk-1C is
expressed in the ventral nerve cord and RNAi experiments
result in motility defects. Another gene mutation which
phenocopies the cgk-1 RNAi is unc-29. unc-29 encodes a
non-a subunit of the nicotinic acetylcholine receptor
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(Fleming et al. 1997). Mutant unc-29 animals exhibit
motility defects during early larva stages (Fleming et al.
1997) and expression studies have shown that unc-29 is
expressed in the ventral nerve cord.
The C. elegans genome sequence contains 29 putative
guanylyl cyclases (Bargmann 1998, 1998). The majority of
these cyclases are predicted to be particulate, and only 6 are
thought to be soluble (Yu et al. 1997). Some of the
particulate cyclases are known to be speci®cally expressed
in neurons (Yu et al. 1997). For example, the guanylyl
cyclase ORD-1 is neuronal and has been reported to
modulate olfaction (L'Etoile and Bargmann 2000). Also,
the guanylyl cyclase DAF-11 has been shown to modulate
chemosensory transduction and dauer formation in
C. elegans (Vowels and Thomas 1992). The functional
role of PQR is not known, but the expression of a guanylyl
cyclase and cgk-1C in PQR suggests that a cGMP signalling
pathway functions in this neuron.
We are now searching for cgk-1 alleles to use in genetic
mosaic analysis to resolve the question of which tissues
must express CGK-1 for normal movement. The fact that we
can screen for mutations that suppress the motility defect
makes it possible to carry out a genetic dissection of
pathways in which CGK-1 is involved and identify
important physiological CGK-1 substrates.
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